Genzyme's plans to grow its multiple sclerosis business in Europe continued with the launch of two new treatments in the Republic of Ireland.
The company, which serves as the biotech arm of French pharma firm Sanofi, today launched the injectable Lemtrada (alemtuzumab) in the country just weeks after oral multiple sclerosis (MS) treatment Aubagio (teriflunomide) hit the market...... Read More - http://www.ms-uk.org/aubagio
MS drugs Lemtrada and Aubagio launched in Ireland
MS drugs Lemtrada and Aubagio launched in Ireland
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post